Literature DB >> 3393180

Microscopic nephrocalcinosis in cystic fibrosis.

S M Katz1, L J Krueger, B Falkner.   

Abstract

Airway, sweat-duct, and other epithelial cells in patients with cystic fibrosis display abnormal ion transport. To test whether the kidney, the organ most exquisitely adapted for ion transport, has a similar defect, we measured the levels of calcium excretion and searched for microscopic nephrocalcinosis in patients with cystic fibrosis. Thirty-eight specimens of kidney tissue were stained for calcium deposits, and 24-hour levels of urinary calcium excretion were measured in 14 patients and 15 control subjects. Microscopic nephrocalcinosis was observed in 35 of the 38 specimens (92 percent), and hypercalciuria (greater than 182 mg per gram of creatinine) in 5 of the 14 patients (36 percent). Notably, nephrocalcinosis was detected near the time of birth (in six patients under one year old, including two neonates and one stillborn infant), which supports the hypothesis that such renal calcium deposits reflect the genomic defect and are not due to longstanding pulmonary dysfunction, chronic infection, therapeutic agents, or disease progression. None of the patients with hypercalciuria or nephrocalcinosis had clinical evidence of renal dysfunction. The finding of microscopic nephrocalcinosis near the time of birth in patients with cystic fibrosis suggests a primary abnormality of calcium metabolism in the kidney. Studies of the pathophysiologic features of the kidney in cystic fibrosis may elucidate the molecular alterations observed in this disorder.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3393180     DOI: 10.1056/NEJM198808043190502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Renal complications following lung and heart-lung transplantation.

Authors:  Paul D Robinson; Rukshana C Shroff; Helen Spencer
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

3.  Elevated sweat potassium, hyperaldosteronism and pseudo-Bartter's syndrome: a spectrum of disorders associated with cystic fibrosis.

Authors:  J Devlin; N S Beckett; T J David
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

4.  The voltage-dependent Cl(-) channel ClC-5 and plasma membrane Cl(-) conductances of mouse renal collecting duct cells (mIMCD-3).

Authors:  J A Sayer; G S Stewart; S H Boese; M A Gray; S H Pearce; T H Goodship; N L Simmons
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

5.  Oxalate and calcium excretion in cystic fibrosis.

Authors:  M A Turner; D Goldwater; T J David
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

Review 6.  The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease.

Authors:  Theodore G Liou
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

7.  Small nuclear RNAs U11 and U12 modulate expression of TNR-CFTR mRNA in mammalian kidneys.

Authors:  Jackson Souza-Menezes; Deepali N Tukaye; Horacio Javier Novaira; William B Guggino; Marcelo M Morales
Journal:  Cell Physiol Biochem       Date:  2008-07-25

8.  Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance.

Authors:  Yasmina Yahiaoui; Mathieu Jablonski; Dominique Hubert; Helen Mosnier-Pudar; Laure-Hélène Noël; Marc Stern; Dominique Grenet; Jean-Pierre Grünfeld; Dominique Chauveau; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

9.  Severe nephropathy in three adolescents with cystic fibrosis.

Authors:  M L Melzi; D Costantini; M Giani; A C Appiani; A M Giunta
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

10.  Sodium chloride deficiency in cystic fibrosis patients.

Authors:  U Ozçelik; A Göçmen; N Kiper; T Coşkun; E Yilmaz; M Ozgüç
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.